Europos Sąjunga - graikų - EMA (European Medicines Agency)

instituto grifols s.a. - Ανθρώπινη φυσιολογική ανοσοσφαιρίνη - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - Άνοσοι οροί και ανοσοσφαιρίνες, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

bpl bioproducts laboratory gmbh (0000011488) dornhofstrasse 34, neu-isenburg, 63263 - anti-d immunglobulin - solution for injection - 50mcg/ml - anti-d immunglobulin (8000031029) 500iu - anti-d (rh) immunoglobulin

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

codal synto ltd (0000003170) 33 theklas lysioti str,dorothea building,6th floor, lemesos, 3030, 51785 - cefalexin monohydrate - capsule,hard - 500mg - cefalexin monohydrate (0023325782) 526mg - cefalexin

Europos Sąjunga - graikų - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - danazol - capsule,hard - 100mg - danazol (0017230885) 100mg - danazol

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - danazol - capsule,hard - 200mg - danazol (0017230885) 200mg - danazol

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - tranexamic acid - solution for injection - 250mg/5ml - tranexamic acid (0001197188) 250mg - tranexamic acid

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - tranexamic acid - solution for injection - 500mg/5ml - tranexamic acid (0001197188) 500mg - tranexamic acid

Kipras - graikų - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - tranexamic acid - solution for injection - 100mg/ml - tranexamic acid (0001197188) 100mg - tranexamic acid